|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-5-12
|
|
pubmed:abstractText |
To assess the degree of awareness of the American College of Rheumatology (ACR) guidelines and package insert information on the screening for and management of hepatitis B virus (HBV) infection by rheumatologists in patients receiving immunomodulation drug therapies.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
2151-4658
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
704-11
|
|
pubmed:meshHeading |
pubmed-meshheading:20461789-Adult,
pubmed-meshheading:20461789-Antirheumatic Agents,
pubmed-meshheading:20461789-Attitude of Health Personnel,
pubmed-meshheading:20461789-Clinical Competence,
pubmed-meshheading:20461789-Cross-Sectional Studies,
pubmed-meshheading:20461789-Guideline Adherence,
pubmed-meshheading:20461789-Hepatitis B,
pubmed-meshheading:20461789-Humans,
pubmed-meshheading:20461789-Immunocompromised Host,
pubmed-meshheading:20461789-Immunomodulation,
pubmed-meshheading:20461789-Mass Screening,
pubmed-meshheading:20461789-Middle Aged,
pubmed-meshheading:20461789-Practice Guidelines as Topic,
pubmed-meshheading:20461789-Recurrence,
pubmed-meshheading:20461789-Rheumatic Diseases,
pubmed-meshheading:20461789-Rheumatology,
pubmed-meshheading:20461789-Time Factors,
pubmed-meshheading:20461789-Virus Activation
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy.
|
|
pubmed:affiliation |
Georgetown University Hospital, Washington, DC, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
